Variable | Survival status | Total | CHR, (95%CI) | AHR, (95% CI) | |
---|---|---|---|---|---|
Event (TB) | Censored | ||||
Sex | |||||
Male | 64 | 115 | 179 | 1.58 (1.13-2.22) | 1.4 (0.99-1.98) |
Female | 72 | 219 | 291 | 1.00 | 1.00 |
Tobacco use | |||||
Yes | 18 | 26 | 44 | 1.64(1.00-2.70) | 1.46(0.85-2.49) |
No | 118 | 306 | 424 | 1.00 | 1.00 |
Functional status | |||||
Working | 79 | 263 | 342 | 1.00 | |
Ambulatory/Bed ridden | 57 | 71 | 128 | 2.27(1.61 3.19) | 1.64(1.13-2.38) |
WHO clinical stage | |||||
I/II | 91 | 11 | 102 | 1.00 | |
III | 202 | 92 | 294 | 3.26(1.74 ,6.10) | 2.88(1.53-5.43) |
IV | 41 | 33 | 74 | 5.55(2.80, 0.99) | 3.82(1.86-7.85) |
CD4 cell count | |||||
<50 | 41 | 36 | 77 | 2.61(1.58-4.30) | 2.13(1.28-3.53) |
50-200 | 196 | 73 | 269 | 1.28(0.82,1.99) | 1.27(0.81-1.98) |
>200 | 97 | 27 | 124 | 1.00 | 1.00 |